Hebei Changshan Biochemical Pharmaceutical Co., Ltd., abbreviated as “Changshan Pharma”(stock code:300255) was established on Sept., 28th, 2000, is a unique heparin manufacturing company with full intergraded industrial chain in China . Our heparin products are sold to many countries in the world such as USA, France, Germany, Italy, Spain, Russia, India, and Japan.
In 2009,Changshan Pharma was approved as innovation enterprise by ministry of science and technology of China . In 2012, Changshan Pharma has established a unique national glycobiology research center . Our small volume injection, tablet, and solid capsule centers have been approved by SFDA as GMP facilities. Our API (Heparin Sodium, Enoxaparin Sodium, Nadroparin Calcium, Dalteparin Sodium) facility has been approved by SFDA, European CEP, France GMP, Japan PMDA, Germany GMP, and US FDA agencies.